KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Total Debt (2016 - 2025)

Idexx Laboratories has reported Total Debt over the past 17 years, most recently at $449.8 million for Q4 2025.

  • Quarterly results put Total Debt at $449.8 million for Q4 2025, down 27.16% from a year ago — trailing twelve months through Dec 2025 was $449.8 million (down 27.16% YoY), and the annual figure for FY2025 was $449.8 million, down 27.16%.
  • Total Debt for Q4 2025 was $449.8 million at Idexx Laboratories, down from $524.8 million in the prior quarter.
  • Over the last five years, Total Debt for IDXX hit a ceiling of $1.4 billion in Q3 2022 and a floor of $449.8 million in Q4 2025.
  • Median Total Debt over the past 5 years was $811.0 million (2021), compared with a mean of $812.7 million.
  • Biggest five-year swings in Total Debt: soared 63.4% in 2022 and later crashed 37.67% in 2023.
  • Idexx Laboratories' Total Debt stood at $848.7 million in 2021, then increased by 11.27% to $944.4 million in 2022, then fell by 26.1% to $697.9 million in 2023, then dropped by 11.51% to $617.6 million in 2024, then fell by 27.16% to $449.8 million in 2025.
  • The last three reported values for Total Debt were $449.8 million (Q4 2025), $524.8 million (Q3 2025), and $1.0 billion (Q2 2025) per Business Quant data.